#USA #Chicago #FDA Approval #AIRS Medical #SwiftMR

AIRS Medical's SwiftMR® Achieves FDA Clearance

AIRS Medical has made a significant stride in the medical imaging field with its SwiftMR® platform, which is now officially cleared by the FDA to operate concurrently with OEM deep learning (DL) reconstruction solutions. This announcement, made on April 15, 2026, highlights a pivotal moment for imaging centers aiming to reduce scan times while maintaining high-quality outcomes.

What is SwiftMR®?

SwiftMR® is an innovative solution designed to enhance MRI image quality while also expediting the scanning process. It has received FDA 510(k) clearance, signifying that it meets rigorous standards for safety and efficacy. The platform is vendor-neutral, meaning it can work alongside equipment from multiple manufacturers, thus providing flexibility and broader applicability across various imaging center setups.

Enhanced Efficiency with OEM Solutions

The FDA clearance allows SwiftMR® to function alongside original equipment manufacturers' deep learning solutions in two primary ways:
1. Complementary Operation: In scenarios where an OEM DL solution is already implemented, SwiftMR® can further reduce scan times. For instance, in an imaging center using a GE 3T scanner equipped with AIR Recon DL, SwiftMR® successfully shortened routine brain scan durations from 15 minutes to just 9 minutes. This improvement illustrates how SwiftMR® can maximize the benefits of existing technologies.
2. Expanding Coverage: When existing OEM DL solutions do not address specific sequences, SwiftMR® steps in to provide comprehensive coverage. This means that facilities can expect AI-powered image enhancement and additional time savings across all pulse sequences and body parts. This capability is backed by clinical usage since 2023, establishing SwiftMR® as a trusted option.

According to Jina Park, Chief Strategy Officer at AIRS Medical, “The difference in scan durations can significantly impact scheduling and patient throughput. If an imaging site can reduce their appointment slots from 30 minutes to 20, it can lead to much more efficient operations.” The additional time savings offered by SwiftMR® can transform how radiology departments plan their workflows.

Rigorous Testing and Training

To ensure the quality and reliability of SwiftMR®, AIRS Medical undertook extensive training for the platform, focusing on images processed by OEM DL systems. Woojin Jung, Head of Product at AIRS Medical, noted that this FDA clearance validates SwiftMR®'s quality. With successful testing across various vendor platforms and field strengths, customers can deploy SwiftMR® confidently within their imaging suites.

Availability and Future Prospects

SwiftMR® is now available for imaging centers and hospitals eager to embrace faster MRI scans and increase efficiency in appointment scheduling. Interested parties can learn more and schedule a demonstration at AIRS Medical's official website, airsmed.com.

About AIRS Medical

AIRS Medical is a pioneering company in the realm of AI-driven medical imaging, aiming to revolutionize MRI processes through advanced deep learning technologies. Their products, including SwiftMR® and the companion solution SwiftSight®, are already utilized in over 1,700 imaging centers in more than 40 countries around the globe.

In summary, AIRS Medical's SwiftMR® represents a transformative step in enhancing MRI efficiency through FDA-approved integration with OEM deep learning solutions, marking a new chapter in medical imaging technology that could redefine patient care standards in radiology.